로킷헬스케어
376900KOSDAQ58.2 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Rocket Healthcare develops a customized treatment platform integrating AI-based wound modeling, personalized bioinks, and 3D bioprinting technologies for regenerative medicine fields such as diabetic foot ulcers, chronic wounds, cartilage regeneration, and kidney treatments. The company focuses on addressing the growing demand driven by aging populations and chronic diseases, as well as the limitations of existing treatments.
Number of Employees
90people
Average Salary
7.5M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Avg ▲52.9% (2-year basis)
Avg ▲66.3% (2-year basis)
Detailed News Sentiment
- Neutral[하우머니] 골 관절염의 다음 답은?
The news discusses a topic related to osteoarthritis industry insights from a financial show but does not directly impact RokitHealthcare's stock performance.
- Positive로킷헬스케어, 美 신장학회서 '신장 재생패치' 효과 공개
로킷헬스케어의 신장 재생 패치 전임상 결과가 긍정적으로 발표되어 주가 상승 기대.
- Positive로킷헬스케어-하버드大, 신장 재생 패치 ‘반대측 신장 기능 강화’ ....
로킷헬스케어의 신장 재생 패치 연구가 하버드 의과대학과의 협업으로 긍정적인 결과를 보여주며 주가 상승 기대.
Detailed Momentum
Near 52w low (8%, downtrend)
1m -13.02% (falling)
Volume decreasing
Detailed Disclosure
- Neutral반기보고서 (2026.06)2026-08-14
